Importance of nutritional support in patients with hepatic encephalopathy;Importancia de la nutrición en enfermos con encefalopatía hepatica

Nutricion Hospitalaria

Volumn 27, Issue 2, 2012, Pages 372-381

  Jurado Garcia J ^a   Costan Rodero G ^a   Calanas Continente A ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Branched chain amino acids; Dietary protein; Hepatic encephalopathy; Malnutrition; Nutritional support

Indexed keywords

HEALTH CARE POLICY; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; NUTRITIONAL ASSESSMENT; NUTRITIONAL SUPPORT; PRACTICE GUIDELINE; PROTEIN CALORIE MALNUTRITION; REVIEW;

GUIDELINES AS TOPIC; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; NUTRITION ASSESSMENT; NUTRITION POLICY; NUTRITIONAL SUPPORT; PROTEIN-ENERGY MALNUTRITION;

EID: 84858727871     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2012.27.2.5517     Document Type: Review

References (68)

1. Italian Multicentre Cooperative Project of on nutrition in liver cirrhosis: Nutritional status in cirrhosis. J Hepatol 1994; 21: 317-25.
2. Müller MJ. Malnutrition in cirrosis. J Hepatol 1995; Suppl. 23: 31-5.
3. Lautz HU, Selberg O, Körber J, Bürger M, Müller MJ. Proteincalorie malnutrition in liver cirrhosis. Clin Investig 1992; 70: 478-86.
4. Gheorghe L, Iacob R, V dan R, Iacob S, Gheorghe C. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet. Rom J Gastroenterol 2005; 14: 231-8.
5. Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G et al. Nutrition and Survival in Patients With Liver Cirrhosis. Nutrition 2001; 17: 445-50.
6. Le Cornu KA, McKiernan FJ, Kapadia SA, Neuberger JM. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation. Transplantation 2000; 69: 1364-9.
7. Chadalavada R, Sappati Biyyani RS, Maxwell J, Mullen K. Nutrition in hepatic encephalopathy. Nutr Clin Pract 2010; 25: 257-64.
8. Kachaamy T, Bajaj JS. Diet and cognition in crhonic liver disease. Curr Opin Gastroenterol 2011; 27: 147-9.
9. Franchis R. Non-invasive diagnosis of cirrhosis and the natural history of its complications. Best Pract Res Clin Gastroenterol 2007; 1: 3-18.
10. Márquez Aguirre AL, Canales-Aguirre AA, Gómez Pinedo, U, Gálvez Castélum, FJ. Aspectos moleculares de la encefalopatía hepática. Neurol 2010; 25: 239-47.
11. Cabral CM, Burns DL. Low-protein diets for hepatic encephalopathy debunked: let them eat steak. Nutr Clin Pract 2011; 26: 155-9.
12. Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 2010; 7: 515-25.
13. Seyan AS, Hughes RD, Shawcross DL. Changing face of hepatic encephalopathy: Role of inflammation and oxidative stress. World J Gastroenterol 2010; 16: 3347-57.
14. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21.
15. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573-83.
16. Bémeur C, Desjardins P, Butterworth RF. Role of nutrition in the management of hepatic encephalopathy in end stage liver failure. J Nutr Metab 2010; 2010: 489823. Epub 2010 Dec 22.
17. Álvares da Silva M, Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition 2005; 21: 113-7.
18. Plauth M, Cabré E, Riggio O, Assis-Camilod M, Pirliche M, Kondrup J. ESPEN Guidelines on Enteral Nutrition: Liver Disease. Clin Nutr 2006; 25: 285-94.
19. Chang WK, Chao YC, Tangs HS, Lang HF, Hsu CT. Effects of extra carbo-hydrate supplementation in the late evening on energy of expenditure and substrate oxidation in patients with liver cirrhosis. J Parenter Enteral Nutr 1997; 21: 96-9.
20. Cabré E, Rodríguez-Iglesias P, Caballería J, Quer JC, Sánchez- Lombraña JL, Parés A, et al. Short and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 2000; 32: 36-42.
21. Cabre E, Gonzalez-Huix F, Abad-Lacruz A, Esteve M, Acero D, Fernandez-Bañares F et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics: a randomized controlled trial. Gastroenterology 1990; 98: 715-20.
22. Kearns PJ, Young H, Garcia G, Blaschke T, O'Hanlon G, Rinki M et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992; 102: 200-5.
23. De Lédinghen V, Beau P, Mannant PR, Borderie C, Ripault MP, Silvain C et al. Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study. Dig Dis Sci 1997; 42: 536-41.
24. Plauth M, Cabré E, Campillo B, Kondrup J, Marchesini G, Schütz T et al. ESPEN Guidelines on Parenteral Nutrition: Hepatology. Clin Nutr 2009; 28: 436-44.
25. Plauth M, Roske AE, Romaniuk P, Roth E, Ziebig R, Lochs H. Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration. Gut 2000; 46: 849-55.
26. Henkel AS, Buchman AL. Nutritional support in patients with chronic liver disease. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 202-9.
27. Owen OE, Trapp VE, Reichard GA Jr, Mozzoli MA, Moctezuma J, Paul P et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 1983; 72: 1821-32.
28. Yamanaka-Okumura H, Nakamura T, Miyake H, Takeuchi H, Katayama T, Morine Y et al. Effect of long-term late-evening snack on health-related quality of life in cirrhotic patients. Hepatol Res 2010; 40: 470-6.
29. Vaisman N, Katzman H, Carmiel-Haggai M, Lusthaus M, Niv E. Breakfast improves cognitive function in cirrhotic patients with cognitive impairment. Am J Clin Nutr 2010; 92: 137-40.
30. Kondrup J, Nielsen K, Juul A. Effect of long-term refeeding on protein metabolism in patients with cirrhosis of the liver. Br J Nutr 1997; 77: 197-212.
31. Kondrup J, Muller MJ. Energy and protein requirements of patients with chronic liver disease. J Hepatol 1997; 27: 239-47.
32. Córdoba J, López-Hellin J, Planas M, Sabin P, Sampedro F, Castro F et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 2004; 41: 38-43.
33. Les I, Planas M, Cárdenas G, Flavià M, Vergara M, Soriano G, et al. Effects of the proteins of the diet in patients with cirrhosis and a prior episode of hepatic encephalopathy. A longterm randomized study. Abstract. Hepatology 2009; 50 (Suppl.): 313A.
34. Keshavarzian A, Meek J, Sutton C, Emery VM, Hughes E, Hodgson HJ. Dietary protein supplementation from vegetable sources in the management of chronic portal systemic encephalopathy. Am J Gastroenterol 1984; 12: 945-49.
35. Bianchi GP et al. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison. J Intern Med 1993; 5: 385-92.
36. Sherlock S. Diseases of the Liver and Biliary System, Blackwell Scientific, 9th edition, 1993.
37. Soeters PB, Fischer JE. Insulin, glucagon, aminoacid imba - lance, and hepatic encephalopathy. Lancet 1976; 2: 880-2.
38. Plauth M, Schütz T. Branched-chain amino acids in liver disea - se: new aspects of long know phenomena. Curr Opin Clin Nutr Metab Care 2011; 14: 61-6.
39. Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branchedchain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev 2003; 2: CD001939.
40. Bienia R, Ratcliff S, Barbour GL, Kummer M. Malnutrition and hospital prognosis in the alcoholic patient. JPEN J Paren - ter Enteral Nutr 1982; 6: 301-3.
41. Blendis LM, Harrison JE, Russell DM, Miller C, Taylor BR, Greig PD et al. Effects of peritoneovenous shunting on body composition. Gastroenterology 1986; 90: 127-34.
42. Holecek, M. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition 2010; 26: 482-90.
43. Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loquercio C et al. Nutritional supplementation with branchedchain amino acids in advanced cirrhosis: a double-blind, randomised trial. Gastroenterology 2003; 124: 1792-801.
44. Stauch S, Kircheis G, Adler G, Beckh K, Ditschuneit H, Görtelmeyer R, et al. Oral L-Ornithine L-Aspartate therapy of crhonic hepatic encephalopathy: Results of a placebo controlled double-blind study. J Hepatol 1998; 28: 856-64.
45. Abdo Francis JM, Pérez Hernández JL, Hinojosa Ruiz A, Hernández Vásquez. Disminución de la estancia hospitalaria con el uso de L-ornitina L-aspartato (LOLA) en pacientes con encefalopatía hepática. Rev Gastrenterol Mex 2010; 75: 135-41.
46. Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Gortelmeyer R et al. Therapeutic efficacy of L-Ornitine LAspartate infusions in patients with cirrosis and hepatic encephalopathy: result of a placebo-controlled, double blind study. Hepatology 1997; 25: 1351-60.
47. Jiang Q, Jiang XH, Zheng MH, Chen YP. L-Ornithine-Laspartate in the management of hepatic encephalopathy: A meta-analysis. J Gastroenterol Hepatol 2009; 24: 9-14.
48. Pereg D, Kotliroff A, Gadoth N, Hadary R, Lishner M, Kitay- Cohen Y. Probiotics for patients with compensated liver cirrhosis: A double-blind placebo-controlled study. Nutrition 2011; 27: 177-81.
49. Sharma P, Sharma BC, Purib V, Kumar Sarin S. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol 2008; 20: 506-11.
50. Malaguarnera M, Gargante MP, Malaguarnera G, Salmeri M, Mastrojeni S, Rampello L et al. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. Eur Gastroenterol Hepatol 2010; 22: 199-206.
51. Bajaj JS, Saeian K, Christensen KM, Hafeezullah M, Varma RR, Franco J et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008; 103: 1707-15.
52. Shukla S, Shukla A, Mehboob, S, Guha S. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther 2011; 33: 662-71.
53. Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003; 2: 413-9.
54. Sanyal AJ Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM et al. Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis. N Eng J Med 2010; 362: 1675-85.
55. Prasad AS. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J Infect Dis 2000; 182: 62-8.
56. Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatol 1996; 23: 1084-92.
57. Rico Hernández MA, Calvo Viñuela I, Gómez Gómez-Lobo E, Dïaz Gómez J. La malnutrición como causa y consecuencia de distorsiones sensoriales. Nutr Hosp 2011; 4 (Suppl. 2): 25-30.
58. Mesejo A, Juan M, Serrano A. Cirrosis y encefalopatía hepá - tica: consecuencias clínico metabólicas y soporte nutricional. Nutr Hosp 2008; 23 (Suppl. 2): 8-18.
59. Takuma Y, Nouso K, Makino Y, Hayashi M, Takahashi H. Clinical trial: oral zinc in hepatic encephalopathy. Aliment Pharmacol Ther 2010; 32: 1080-90.
60. Reding P, Duchateau J, Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomized controlled trial. Lancet 1984; 12: 493-5.
61. Van Gossum A, Nève J. Low selenium status in alcoholic cirrhosis is correlated with aminopyrine breath test: preliminary effects of selenium supplementation. Biol Trace Elem Res 1995; 47: 201-7.
62. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324: 1852-7.
63. Bjelakovic G, Gluud L, Nikolova D, Bjelakovic M, Nagorni A, Gluud C. Meta-analysis: antioxidant supplements for liver disea ses - the Cochrane Hepato-Biliary Group. Aliment Pharmacol Ther 2010; 32: 356-67.
64. Lévy S, Hervé C, Delacoux E, Erlinger S. Thiamine deficiency in hepatitis C virus and alcohol-related liver disease. Dig Dis Sci 2002; 3: 543-48.
65. Newsome PN, Beldon I, Moussa Y, Delahooke TE, Poulopoulos G, Hayes PC et al. Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease. Aliment Pharmacol Ther 2000; 10: 1295-301.
66. Gundling F, Teich N, Strebel HM, Schepp W, Pehl C. Nutrition in liver cirrhosis. Medizinische Klinik 2007; 102: 435-44.
67. Malaguarnera M, Vacante M, Giordano M, Pennisi G, Bella R, Rampello L et al. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Am J Clin Nutr 2011; 93: 799-808.
68. Wilkinson DJ, Smeeton NJ, Watt PW. Ammonia metabolism, the brain and fatigue; revisiting the link. Prog Neurobiol 2010; 91: 200-19.